Literature DB >> 3996059

Regional myocardial blood flow in man during dipyridamole coronary vasodilation.

S G Sorensen, B M Groves, L D Horwitz, T K Chaudhuri.   

Abstract

Regional myocardial blood flow before and after intravenous dipyridamole (0.56 mg/kg) was measured during cardiac catheterization in 11 patients using the 133Xe washout technique. Significant increases in heart rate (75 +/- 4 vs 87 +/- 6, p less than 0.004) and decreases in systolic blood pressure (144 +/- 8 vs 131 +/- 7, p less than 0.02) were observed with dipyridamole infusion. However, double product and cardiac output did not differ before or after drug infusion. Regional myocardial blood flow increased from 67 +/- 3 (SEM) to 117 +/- 3 ml/100 mg/min in myocardial segments supplied by nonobstructed coronary arteries. In stenotic coronary arteries, flow increased from 57 +/- 5 to 79 +/- 9 ml/100 mg/min with dipyridamole. We conclude that dipyridamole infusion results in flow differences which discriminate stenotic from nonstenotic coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3996059     DOI: 10.1378/chest.87.6.735

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  A comparison of maximal exercise and dipyridamole thallium-201 planar gated scintigraphy.

Authors:  W Martin; A C Tweddel; G Main; I Hutton
Journal:  Eur J Nucl Med       Date:  1992

2.  Myocardial 201Tl washout after combined dipyridamole submaximal exercise stress: reference values from different patient groups.

Authors:  L Fridrich
Journal:  Eur J Nucl Med       Date:  1989

3.  Internal validation of myocardial flow reserve PET imaging using stress/rest myocardial activity ratios with Rb-82 and N-13-ammonia.

Authors:  Daniel Juneau; Kai Yi Wu; Nicole Kaps; Jason Yao; Jennifer M Renaud; Rob S B Beanlands; Terrence D Ruddy; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2021-01-03       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.